While beneficial effects of SIRT2 inhibition was shown in neurodegenerative diseases such as Parkinson's and Huntington's disease, the role of SIRT2 in cancer remains controversial [15, 16]. The gene discussed is SIRT2; the disease is Parkinson disease.